Portfolio (Quarterly)
Guide ↗
LETKO, BROSSEAU & ASSOCIATES INC
· CIK 0001297496| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 81 | ERO | ERO COPPER CORP | Basic Materials | 14,700.0 | $390K | 0.01% | — | — | $26.56 | +40.8% |
| 82 | — | NEWAMSTERDAM PHARMA COMPANY | — | 11,775.0 | $377K | 0.01% | — | — | $32.01 | — |
| 83 | ELVN | ENLIVEN THERAPEUTICS INC | Healthcare | 9,600.0 | $376K | 0.01% | NEW | — | $39.20 | +17.4% |
| 84 | NXPI | NXP SEMICONDUCTORS N V | Technology | 1,775.0 | $349K | 0.01% | — | — | $196.86 | +20.0% |
| 85 | GOOGL | ALPHABET INC | Communication Services | 1,092.0 | $314K | 0.01% | — | — | $287.56 | +19.2% |
| 86 | MGTX | MEIRAGTX HLDGS PLC | Healthcare | 32,000.0 | $277K | 0.00% | — | — | $8.66 | +28.3% |
| 87 | — | AMRIZE LTD | — | 4,941.0 | $268K | 0.00% | — | — | $54.18 | — |
| 88 | CABA | CABALETTA BIO INC | Healthcare | 90,475.0 | $243K | 0.00% | — | — | $2.69 | -25.7% |
| 89 | BCAX | BICARA THERAPEUTICS INC | Healthcare | 11,175.0 | $222K | 0.00% | — | — | $19.89 | -5.5% |
| 90 | KMB | KIMBERLY-CLARK CORP | Consumer Defensive | 2,240.0 | $216K | 0.00% | NEW | — | $96.47 | +2.4% |
| 91 | ORCL | ORACLE CORP | Technology | 1,420.0 | $209K | 0.00% | — | — | $147.11 | -9.8% |
| 92 | SPRY | ARS PHARMACEUTICALS INC | Healthcare | 24,700.0 | $198K | 0.00% | — | — | $8.03 | -48.6% |
| 93 | AURA | AURA BIOSCIENCES INC | Healthcare | 28,300.0 | $189K | 0.00% | — | — | $6.69 | -8.1% |
| 94 | — | TENAX THERAPEUTICS INC | — | 10,650.0 | $170K | 0.00% | — | — | $15.99 | — |
| 95 | AQST | AQUESTIVE THERAPEUTICS INC | Healthcare | 35,325.0 | $147K | 0.00% | — | — | $4.15 | +14.5% |
| 96 | TCRX | TSCAN THERAPEUTICS INC | Healthcare | 95,875.0 | $97K | 0.00% | — | — | $1.01 | -66.3% |
| 97 | REPL | REPLIMUNE GROUP INC | Healthcare | 10,800.0 | $83K | 0.00% | — | — | $7.65 | +64.2% |
| 98 | ALDX | ALDEYRA THERAPEUTICS INC | Healthcare | 17,300.0 | $29K | — | — | — | $1.69 | -31.4% |
| 99 | PROK | PROKIDNEY CORP | Healthcare | 15,900.0 | $28K | — | — | — | $1.79 | -10.1% |
| 100 | HUMA | HUMACYTE INC | Healthcare | 45,950.0 | $28K | — | — | — | $0.61 | -9.8% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Financial Services
32.0%
Communication Services
15.9%
Basic Materials
11.6%
Technology
10.5%
Healthcare
9.8%
Consumer Cyclical
6.3%
Industrials
5.6%
Energy
4.4%
Utilities
2.9%
Real Estate
0.6%